Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial (Q45552005)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2004

Language	Label	Description	Also known as
English	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial	scientific article published in November 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

human papilloma virus

1 reference

object named as

human papillomavirus

29 September 2024

based on heuristic

inferred from title

Eduardo L. Franco

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Cosette M Wheeler

3

object named as

Cosette Wheeler

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

15

object named as

Wim Quint

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Diane M Harper

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Daron G Ferris

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

David Jenkins

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Anne Schuind

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Toufik Zahaf

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Paulo Naud

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Newton S De Carvalho

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Cecilia M Roteli-Martins

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Julio Teixeira

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Mark M Blatter

13

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Abner P Korn

14

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gary Dubin

16

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

GlaxoSmithKline HPV Vaccine Study Group

17

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

364

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

9447

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1757-1765

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer burden in the year 2000. The global picture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term fluctuations in the detection of cervical human papillomavirus DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting the detection rate of human papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chapter 16: Prophylactic human papillomavirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving vaccine performance with adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Papillomavirus vaccines in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus vaccines and prevention of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917398-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)17398-4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45552005&oldid=2254309590"